10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
INTUITIVE SURGICAL INC | |||
Ticker: ISRG Fiscal Year: 2021 | |||
Consolidated Statements Of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 3, 2022) | |||
(In Thousands, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
Operating activities: | |||
Net income | $ 1,728,100 | 1,066,800 | 1,381,800 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and loss on disposal of property, plant, and equipment, net | 282,800 | 226,400 | 160,000 |
Amortization of intangible assets | 27,400 | 49,800 | 43,000 |
Loss (gain) on investments, accretion of discounts, and amortization of premiums on investments, net | 10,600 | (55,100) | (6,000) |
Deferred income taxes | (62,600) | 57,600 | (8,000) |
Share-based compensation expense | 449,200 | 395,400 | 335,800 |
Amortization of contract acquisition assets | 22,000 | 17,100 | 13,100 |
Changes in operating assets and liabilities, net of effects of acquisitions: | |||
Accounts receivable | (142,300) | 5,700 | 38,800 |
Inventory | (256,000) | (170,100) | (360,500) |
Prepaids and other assets | (204,900) | (111,800) | (116,900) |
Accounts payable | 36,000 | (32,300) | 12,300 |
Accrued compensation and employee benefits | 115,100 | (16,600) | 57,400 |
Deferred revenue | 32,600 | 15,000 | 35,500 |
Other liabilities | 51,400 | 36,900 | 11,900 |
Net cash provided by operating activities | 2,089,400 | 1,484,800 | 1,598,200 |
Investing activities: | |||
Purchase of investments | (6,452,000) | (4,292,900) | (3,346,200) |
Proceeds from sales of investments | 84,900 | 800,700 | 107,300 |
Proceeds from maturities of investments | 4,267,800 | 2,930,800 | 2,569,800 |
Purchase of property, plant, and equipment and intellectual property | (353,500) | (341,500) | (425,600) |
Acquisition of businesses, net of cash | 8,700 | 37,700 | 59,700 |
Net cash used in investing activities | (2,461,500) | (940,600) | (1,154,400) |
Financing activities: | |||
Proceeds from issuance of common stock relating to employee stock plans | 276,500 | 308,800 | 272,800 |
Taxes paid related to net share settlement of equity awards | (211,600) | (175,200) | (159,100) |
Repurchase of common stock | 0 | (134,300) | (269,500) |
Capital contribution from noncontrolling interest | 0 | 0 | 10,000 |
Payment of deferred purchase consideration | (21,900) | (85,000) | (22,600) |
Net cash provided by (used in) financing activities | 43,000 | (85,700) | (168,400) |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (3,400) | (2,600) | (2,200) |
Net increase (decrease) in cash, cash equivalents, and restricted cash | (332,500) | 455,900 | 273,200 |
Cash, cash equivalents, and restricted cash, beginning of year | 1,638,500 | 1,182,600 | |
Cash, cash equivalents, and restricted cash, end of year | 1,306,000 | 1,638,500 | 1,182,600 |
External Links | |
INTUITIVE SURGICAL INC (ISRG) Fiscal Year 2021 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |